Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy
Condition(s):Bacterial Infection Due to Helicobacter Pylori (H. Pylori)Last Updated:April 6, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Bacterial Infection Due to Helicobacter Pylori (H. Pylori)Last Updated:April 6, 2012Unknown status
Condition(s):Helicobacter Infections; Gastritis; Gastric Ulcer; Duodenal UlcerLast Updated:September 11, 2006Unknown status
Condition(s):Gastritis; Gastric UlcerLast Updated:February 24, 2016Unknown status
Condition(s):Bacterial InfectionsLast Updated:September 21, 2020Completed
Condition(s):Invasive Fungal InfectionLast Updated:April 20, 2022Completed
Condition(s):Invasive Fungal InfectionsLast Updated:February 10, 2022Completed
Condition(s):Aspergillosis Invasive; Fungal InfectionLast Updated:November 3, 2020Completed
Condition(s):Bacterial InfectionsLast Updated:October 18, 2018Completed
Condition(s):Peptic Ulcer With H. Pylori Infection; Gastritis With H. Pylori InfectionLast Updated:November 23, 2005Unknown status
Condition(s):Helicobacter Pylori InfectionLast Updated:October 8, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.